- UHS to roll out behavioral health revenue cycle AI tools in 2026
- WVU Medicine hospital names interim CEO
- University Hospital COO to lead Main Line Health hospital
- 15 dentists making headlines
- What’s driving clinicians to quit, stay
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- The biggest threats to the ASC model
- Oracle loses leaders in health division: Report
- RFK Jr. names 2 new members to CDC vaccine panel
- 10 providers seeking RCM talent
- 10 providers seeking RCM talent
- Carteret Health Care breaks ground on $50M outpatient campus, ASC
- FDA lifts hold on Intellia trial
- PDS Health added de novos across 3 states in February
- Infectious disease fellowships see decline in applicants, filled spots
- Novant posts 4.8% operating margin in 2025
- Novant posts 4.8% operating margin in 2025
- Texas hospitals to merge under Tenet lease agreement
- Oracle Health in the last 30 days
- The anesthesia physician shortage by state, by 2036
- Cleveland Clinic posts $913M operating income, 5% margin — 7 things to know
- Rutgers to unveil preventive cardiology program
- Atlanta GI practice to pay $4.75M for false claims allegations
- Clinician Engagement: The Operating Lever Behind Margin and Throughput
- Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- 11 behavioral health executive moves to know
- 3 behavioral healthcare M&A deals in 2026
- New York City to invest $20M in perinatal mental health
- Anthem Blue Cross of California pushes E/M downcoding policy to April
- States shaping behavioral health parity enforcement: 7 things to know
- The expanding role of ASCs in orthopedic surgeries
- ‘Taking the finances off the table’: Sanford COO talks alignment with health plans
- Sarasota Memorial disputes OIG audit alleging $12.1M in Medicare overpayments
- The highest-paid gastroenterologist in the 10 largest Midwestern cities
- Sending clinicians on 911 calls: What to know from this Michigan pilot
- Sentara brings in new wave of ambulatory, surgical leadership
- Iowa dentist surrenders license
- Temple University gets approval for $3.19M rural dental clinic
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- California weighs legislation to increase dental plan transparency: 5 things to know
- Dentsply Sirona launches restructuring plan: 8 notes
- American Academy of Pediatric Dentistry opposes EPA fluoride assessment plan: 7 notes
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- San Francisco OKs performance-based sobering center
- Clover Health CEO said company sees opportunity in complex MA environment
- Georgia School of Orthodontics appoints interim COO
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Top 10 dental, DSO stories in February
- Aria Care Partners acquires Georgia dental provider
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- Blood Test Can Predict Short-Term Survival Among Seniors
- How the Brain Learns to Have Seizures During Sleep
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up
- Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
- Oceans Healthcare taps behavioral hospital CEO
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Inside Children’s of Alabama’s approach to de-escalation training
- Partnering to Advance Drug Delivery Innovation
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- What the Health? From KFF Health News: What About the State of Health?
- 10 behavioral health leaders’ ‘North Star’ in turbulent times
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- UHS expects $35M earnings hit from California psychiatric staffing mandate
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod
- 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Cientos de enfermeros estadounidenses dejan atrás el Estados Unidos de Trump y eligen trabajar en Canadá
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Could Drone-Delivered Defibrillators Save Lives?
- Eisai points the way to kidney cancer support with Kompass digital hub
- Sarepta CEO Doug Ingram to retire after a decade of Duchenne breakthroughs and controversies
- Inflammation Linked To Brain Damage, Memory Problems Among Football Players
- Early Birds, Active Folks Less Likely To Develop ALS
- Disasters Can Affect Mental Health A Decade Later, Review Finds
- AI Chatbots Can Contribute To Worsening Mental Illness, Study Finds
- Newborns Exposed to More ‘Forever Chemicals’ Than Once Thought
- Study Highlights Unique Parenting Struggles of Younger Patients With Heart Disease
- Altman-backed startup Verifiable rolls out AI agent to automate credentialing
- ‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada Over Trump’s America
- ‘Kind of Morbid’: Health Premiums Threaten Their Nest Egg. A Terminal Diagnosis May Spare It.
- OpenEvidence releases AI-integrated dialer feature to expand its reach with clinicians
- CMS unveils new initiatives aimed at cracking down on healthcare fraud
- After 2025's volumes shortfall, Universal Health Services says capacity, headcount investments will pay off in 2026
- GSK's ViiV confirms staying power of long-acting HIV treatment Cabenuva in adolescents
- A new standard? Merck's Welireg combos deliver 1-2 punch to kidney cancer
- Operating a New Standard for Life-Saving Pharmaceutical Logistics
- Add-Only Retro Programs Are Now a Federal Red Flag. Here's the Evidence.
- Surgeon general nominee Casey Means faces Senate grilling on vaccines, conflicts of interest
99MTechnetium-pyrophosphate (PYP) is a radionuclide isotope widely used for imaging and diagnostic purposes. It is the most common radioactive isotope tracer used for SPECT (single-photon emission computerized tomography) imaging of the brain, bones, lungs, kidneys, thyroid, heart, gall bladder, liver, spleen, bone marrow, salivary glands, lachrymal glands, and sentinel nodes.
Both major U.S. suppliers, Curium and Sun Radiopharma, have notified American and Canadian radiographers of a complete and total supply disruption. Here is Sun's notice:
Sun-Radiopharma-Supply-Update_12-01-2023.jpg
Sun Radiopharma seems to think that 99MTechnetium-pyrophosphate (PYP) will be available again early next year. This would be a much shorter duration than the two year shortage which developed back in 2009.
This shortage is not an FDA screw up, rather it is caused by the atomic energy authorities of several countries acting in concert. 99MTechnetium-pyrophosphate (PYP) is isolated from the decay of 99Molybdenum, which is in turn produced by exposing highly enriched 235Uranium (HEU) targets to the neutron flux in a nuclear reactor. After 9/11, atomic energy authorities decided to force new processes using low enriched 235Uranium (LEU) targets on the radionuclide producers to prevent nuclear proliferation.
The LEU based processes were forced on the industry before they were ready for prime time, and the HEU processes were ended prior to a reliable supply of LEU produced 99MTechnetium-pyrophosphate (PYP) was established. This created a severe supply disruption back in 2009, which was resolved by restoring the HEU process. It appears that the current shortage is due to a second effort to require LEU target production processes exclusively.
The U.S. Nuclear Regulatory Commission (NRC) is not getting any public notice for this fiasco, but they are indeed responsible for it.
So if I understand this right, healthcare once again pays the penalty for winner-take-all law enforcement policies.
This situation is an example of complete incompetence demonstrated by a government institution which focuses exclusively on public relations, to the detriment of end users. NRC is actually fairly competent within its sphere, but doesn't look beyond that sphere in its decisionmaking.
The 235Uranium (HEU) targets required for 99MTechnetium-pyrophosphate (PYP) production are easily managed by the extremely well armed DoE security apparatchiks. We are not talking a lot of 235Uranium here. Not enough to make even a small fission bomb even if terrorists captured every HEU target shipment in a year. But post 9/11, NRC wanted to show that it was at the forefront of antiterrorist efforts. So they demanded changes to a perfectly satisfactory process which resulted in a new process which simply did not reliably produce an acceptable product.
No one spoke for the medical community, much less the very sick patients who depend upon the radioimaging magic of 99MTechnetium-pyrophosphate before the NRC.
So patients get screwed. And NRC can hide behind "supply disruptions"
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
Friends of MHF
Kirsten DeVries
Tom & Karen Nunheimer
Steve Ahonen
Ron & Faith Bosserman
Marlin & Kathy Klumpp
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
